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R2-Microglobulin (,Q2m)' is the light chain (12 kD) of class I MHC proteins. It
is expressed on the surface ofalmost all nucleated cells in noncovalent association
with a transmembrane heavy chain (-42 kD) glycoprotein encoded within the
MHC (l, 2). The gene encoding a ,Q2m is unlinked to the MHC and is located
on chromosome 2 in mouse (3, 4) and chromosome 15 in man (5). While (02m
shows very little variation within a species, the associated heavy chain molecules
are extremely polymorphic (6).
Cell surface expression of the heavy chains of class I MHC molecules is
generally thought to require concomitant expression of ,d2m (7-13). This con-
clusion has been based on studies of the human Daudi cell line (7-9) and of
mutants of the mouse R1 cell line (10-13). In both systems mutations in the 02m
gene are accompanied by lack of expression of 02m protein and lack of cell
surface class I molecules. Cell surface expression of class I proteins was shown to
be restored in each of these mutant cell lines after fusion to cells that express
normal /02m protein (7, 8, 11, 13). Although these studies provide strong support
for the requirement of /02m protein for cell surface class I expression, they are
not conclusive, and recent data have suggested that the H-21)6 molecule can be
detected on the cell surface in the absence of #2m (14-16) . We therefore
attempted to correct the presumed defect in the Daudi cell line in a more direct
way by transfecting the mouse #2m gene into this cell line. Our results conclu-
sively show that ,d2m protein is essential for the cell surface expression of the
MHC class I antigens of Daudi cells.
Materials and Methods
(:ell Lines.
￿
Daudi, a human Burkitt lymphoma cell line (17), was maintained in RPM1
1640 supplemented with I mM sodium pyruvate, 2 MM L-glutamine, and 10% heat-
inactivated FCS or human serum . CTL lines were generated and characterized essentially
as described (18). Briefly, PBLs from a normal donor (HLA A3,3; B7,7; DR6,6) were
separated on Ficoll-hypaque and stimulated in primary culture with irradiated (10,000
rad) EBV-transformed B cell lines that express HLA-A2 and/or HLA-B17 . Cells were
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stimulated in secondary culture with a different HLA-A2+ and/or HLA-B17' B lympho-
blastoid cell and cloned on a third cell line. Clones arising at 1 cell/well were tested for
lysis ofa panel of 11 target cells expressing HLA-B17, seven targets expressing HLA-A2,
and six targets expressing other HLA types. Clones exhibiting desired specificities were
subdoned at 0.3 cells/well.
Cotransfection of theMouse,02m Gene with pSV2neo.
￿
A 14-kb Xho I fragment containing
the (02m gene from a C57BL/6 mouse (b allele of 02m) was isolated from the phage clone
Ch4A.B2-C57 (12) and was cotransfected into Daudi cells with pSV2neo (19), which
contains the pBR322 origin of replication, the ,B-lactamase gene, and the neomycin
resistance gene. Daudi cells were transfected by electroporation (20) essentially as de-
scribed (21). 2 x 107 cells, 30 ug of the 14-kb Xho I fragment containing the 02m gene,
and 10 Ag of linearized (Bam HI) pSV2neo were mixed in 0.5 ml of 140 mM NaCl, 25
mM Hepes, and0.75 mM Na2HPOa, pH 7.15. A bank of capacitors (effective capacity 14
AF) charged to 1,100 V was discharged via an electronic switch (model ZA 1,000;
Prototype Design Service, Madison, WI) through the sample using a cell chamber
(Prototype Design Service) with a length of 5 mm and a cross-sectional area of 1 cmz at
4°C. After the shock, the cells were left 10 min on ice, then 30 min at 37°C. The cell
suspension was then dispersed into four culture flasks with 20 ml of medium per flask. 2
d after transfection, the antibiotic G418 was added to the flasks to a final concentration
of I mg/ml. 3-wk after transfection,an aliquotof the G418-resistant cells was stained with
mAbs for immunofluorescence analysis.
mAbs for Immunofluorescence Staining.
￿
mAbs W6/32 (22) and PA2.6 (23), which iden-
tify framework components of HLA-A, -B and -C heavy chains, MA2.1 (24), which reacts
specifically with HLA-B17 and HLA-A2, and BBM.1 (25), which reacts with human 02m,
were kindly provided by Dr. P. Parham, Stanford University, Stanford, CA. mAb specific
for the b allele of mouse 02m was purchased from New England Nuclear, Boston, MA.
AH7.2 (IgG2) and G12.2 (IgGI) are mouse anti-rabbit IgG mAbs used as isotype-
matched controls for W6/32 (specific mAb is IgG2, but an IgGI mAb is also secreted
from the fusion partner), BBMA (IgG2b), PA2.6 (IgGI), and MA2.1 (IgGI). Anti-Leu-
2b (IgG2a) (Becton Dickinson & Co., Mountain View, CA) is a mouse mAb specific for
human CD8 and was used as an isotype-matched control for the mouse anti-02m° mAb
(IgG2a).
Immunofluorescence Staining.
￿
Cells were stained with the mAbs described above fol-
lowedby fluorescein-conjugated goat anti-mouse IgGantibodies as a second-stage reagent
(Jackson Immunoresearch Laboratories, West Grove, PA) and analyzed or sorted on the
FACS.
DNA Probes. cDNA probes for the human 132m and HLA-A,B,C mRNA were as
previously described (26) . A 600-bp Sac I-Kpn I genomic fragment containing exon II of
the /02m gene and flanking intron sequence was used as a probe for mouse 132m (12). All
probes were isolated and labeled with RAP by random hexamer priming(27).
RNA Gels and Hybridization. RNA was extracted from cells using the method of
Chirgwin et al. (28). 10-Itg RNA samples were subjected to electrophoresis through a
1.5% agarose gel containing 2.2 M formaldehyde and transferred to nitrocellulose (29).
Blots were hybridized as described (30) to "P-labeled HLA-A, -B, -C, human 132m, or
mouse 132m DNA probes. The filters were washed as described(30) and exposed to XAR-
5 film (Kodak) at -70°C overnight. The positions of the 18S and 28S ribosomal RNA
markers were determined by the ethidium bromide-staining pattern of the gel before
blotting. For rehybridization, the blot was boiled in 0.1 x SSC and 0.1 % SDS for 5 min
three times to remove hybridized probe and then was checked by exposure to XAR-5
film (Kodak) at -70'C overnight.
Cytotoxicity Assay.
￿
"Chromium-release assays were performed in triplicate in V-bot-
tomed wellsas described (31) .
Results
Surface Expression ofHLA Molecules on Daudi Cells.
￿
Although Daudi cells do
not express class I molecules (HLA-A, -B, or -C) on the cell surface, the heavy
chain specificities of this cell line have been identified as A1, A26, B17, and B38290
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FIGURE 1 . Daudi cells transfected with the mouse
02m gene express surface class I MHC molecules.
Untransfected Daudi cells (A, C, and E) and mouse
#2m-transfected Daudi cells (ms2m-Daudi-IA) (B, D,
andF) were stained with an HLA class I-specific mAb
(solid lines) or an isotype-matched control mAb (dotted
lines), followed by FITC-conjugated goat anti-mouse
antibodies. Specific mAbs used were the mono-
morphicanticlass I mAbs W6/32 (A andB) and PA2.6
(C and D), or mAb MA2.1, which is specific for the
HLA-B17 heavychain (E and F).
by their expression on somatic cell hybrids between Daudi and human or mouse
cell lines (8). If the lack of cell surface class I expression of Daudi cells is solely
due to the absence of 02m protein, then transfection and expression of either
the human or mouse 02m gene should rescue expression of these HLA specific-
ities. We therefore cotransfected a DNA fragment containing the mouse #2m
gene and linearized plasmid pSV2neo into Daudi cells by electroporation . Trans-
fectants were selected by resistance to the antibiotic G418, stained with an mAb
(W6/32) specific for a monomorphic determinant on class I HLA molecules,
followed by a fluoresceinated goat anti-mouse Ig second-stage reagent, and then
analyzed on the FRCS. 1-5% of the total transfected Daudi cells stained brightly
at the first FAGS analysis. ^"2,000 positive cells were sorted sterilely from each
of four flasks and maintained independently in culture. One such sorted line,
mo2m-Daudi-1 A, was used for further study. This line was stained with a series
of mAbs that detect surface expression of class I HLA molecules. As shown in
Fig. 1, the transfected Daudi cells (m#2m-Daudi-1A) stained brightly with two
mAbs specific for monomorphic determinants on class I HLA molecules, W6/32
(Fig. 1 B) and PA2.6 (Fig. 1 D), and with an mAb specific for HLA-B17 or HLA-
A2, MA2.1 (Fig. 1 F) as compared with isotype-matched control mAbs. In
contrast, there was no difference between the staining of untransfected Daudi
cells with these mAbs as compared with the isotype-matched control mAbs (Fig.
1, A, C, and E). Surprisingly, we did find greater staining of the transfected
mo2m-Daudi-IA cells than the untransfected Daudi cells with the irrelevant
IgGI control mAb (G12 .2) (Fig. 1, C,-F), but not with the IgG2 control (AH7 .2)
(Fig. 1, A and B). We do not yet know the mechanism for this, but it is possible
that expression of ,Q2m protein or of surface class I molecules increases the
expression of Fc receptors for IgGI . This possibility is currently being investi-
gated.
m02M-Daudi-1A Express Mouse ,Q2m Molecules on Cell Surface.
￿
If the expression
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FIGURE 2.
￿
Daudicellstransfected with
the02mgene express cell surface mouse
02m. Daudi cells were cotransfected
with the mouse (o2m) gene and
pSV2neo. Transfectants were selected
by resistance to theantibiotic G418. Un-
transfected Daudi cells (A) and trans-
fected (B) mo2m-Daudi-IA cells were
stained with an mAb specific for the b
allele of mouse 02m (solid lines) or an
isotype-matched control (dotted line), fol-
lowed by FITC-conjugated goat anti-
mouseantibodies.
FIGURE 3.
￿
Mouse02mcanexchange with hu-
man02m in human serum. Untransfected (dot-
ted lines) and mom-Daudi-1A cells (solid lines)
were grown in either FCS (A andB) or human
serum (C and D). Cells were then stained with
a mAbspecific fortheb allele of mouse 02m (A
and C) or mAbBBM.1, specific forhuman 02m
(B and D), followed by FITC-conjugated goat
anti-mouse antibodies.
of HLA class I molecules on the surface of m#2m-Daudi-IA results from
expression of the transfected mouse ,#2m gene, then the transfectants should
also express cell surface mouse #2m. Fig. 2 shows that an mAb specific for the b
allele of mouse l2m stained the transfectants brightly (Fig. 2B) as compared with
untransfected Daudi cells (Fig. 2A). These results confirm that human HLA class
I surface expression can be rescued in Daudi cells by the provision of a source
of #2m within the cell.
Exchange ofMouse ,02m with Human 02Min Serum.
￿
Class I MHC molecules are
anchored to the cell by the heavy chain, which fully traverses the plasma
membrane . In contrast, ,#2m is located entirely outside the cell with no direct
attachment to the lipid bilayer. Furthermore, the association between ,02m and
class I heavy chains is noncovalent. It is therefore not entirely surprising that
,Q2m associated with class I heavy chains on the cell surface has been shown to
exchange with free #2m present in serum used to grow cultured cells (32-34).
We examined whether mouse #2m expressed on the surface of the m#2m-Daudi-
1A transfectants couldexchange with human 02m by growing the cells in medium
containing human serum instead of FCS. When m02m-Daudi-IA cells were
grown in medium containing FCS, they stained positively only with an mAb
specific for mouse ,02m and not with mAb BBM.1, specific for human (02m (Fig.
3, A and B). In contrast, when these transfected cells were grown in medium
containing human serum, they were stained by both of these mAbs (Fig. 3, C
and D). Interestingly, mo2m-Daudi-IA cells stained more brightly with the anti-
mouse 02m mAb when grown in human serum as compared with FCS. This is292
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FIGURE 4.
￿
Transfected
Daudi cells are recognized by
CTLs for HLA-1317 . Reactiv-
ities of two class I-specific
CTL clones for /32m-Daudi-
1 A and untransfected Daudi
cells were assessed in a chro-
mium release assay . Clone
AMSHA0 (A) is specific for
HLA-1317, while clone AM-
813.2 (B) is specific for a deter-
minant shared by HLA-1317
and HLA-A2 . Target cells in-
cluded untransfected Daudi
cells (open symbols), Daudi
cells transfected with pSV2neo alone (solid symbols), and Daudi cells cotransfected with mouse /#2m
and pSV2neo(m,B2m-Daudi-IA) (half-felled symbols) . Cells were grown either in medium containing
FCS (circles) or human serum (triangles) .
likely to be a consequence of the greater concentration of free 02m in FCS as
compared with human serum (33). As a result, once steady state is achieved, a
greater percentage of cell surface ,Q2m (mouse) will have exchanged with serum
02m (fetal bovine or human 02m, respectively) when the cells are grown in FCS
as compared with human serum .
(,'ell-mediated Cytotoxicity.
￿
Since the human class I HLA/mouse 02m hetero-
dimers on the surface of mo2m-Daudi-1A cells retained serological reactivity
with mAbs specific for human class I molecules, we next examined their func-
tional role as targets for cytotoxicity . Two human CTL clones were used,
AMSH .10, which is specific for HLA-1317, and AM8B.2, which is specific for a
determinant shared by both HLA-A2 and HLA-1317 . Both of these CTL clones
lysed the mo2m-Daudi-IA cells but not untransfected cells or Daudi cells trans-
fected with pSV2neo alone (Fig . 4) . Furthermore, there was no significant
difference in cell-mediated cytotoxicity whether the target mo2m-Daudi-IA cells
were grown with FCS or with human serum (Fig . 4) .
Expression of 02m and HLA Heavy Chain mRNA in Daudi Cells and 02m
Transfectants . The expression of human and mouse ,02m and HLA-A,B,C
mRNA in mf2m-Daudi-IA was examined by Northern blot analysis . As shown
in Fig . 5, equal levels of class I heavy chain mRNA were present in untransfected
Daudi cells and in mo2m-Daudi-1A (Fig . 5, A and B) . As expected, only mfl2m-
Daudl-IA expressed mRNA that hybridized to a mouse ,Q2m probe under high
stringency conditions (Fig . 5, C and D) . The two mouse 02m transcript sizes
detected in mo2m-Daudi-IA correlate with those seen in normal mouse cells
which express02m . The Northern blot hybridized to the mouse 02m probe was
boiled to remove hybridized probe and rehybridized at high stringency to a
human ,Q2m cDNA probe (Fig . 5, E and F) . A transcript of the appropriate size
was detected both in untransfected Daudi cells and in mo2m-Daudi-IA . Surpris-
ingly, the level of human fl2m mRNA in m#2m-Daudi-IA was decreased sever-
alfold compared with that in the untransfected cells . Since the mo2m-Daudi-1 A
line represents a pool rather than a clone of transfectants, this is not likely to be
a result of clonal variation. We do not yet know the mechanism for this decrease
in endogenous ,Q2m RNA. It is possible that synthesis ofa functional ,Q2m protein
or a fully assembled heterodimeric class I molecule in some way results inSEONG ET AL .
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FIGURE 5 .
￿
Expression ofHLA heavy chain and 02mmRNA in Daudi cells and transfectants.
Total RNA was isolated from untransfected (A, C, and E) and transfected m#2m-Daudi-IA
cells (B, D, and F) and a Northern blot was prepared . Lanes A and B were hybridized to a
humanHLA class I cDNA probe . Lanes CandD were hybridized to a mouse fl2m genomic
probe, then rehybridized, after boiling off the probe, to a human ,82m cDNA probe (lanes E
and F) .
feedback inhibition of transcription of the endogenous 02m gene, or perhaps
the transfected mouse ,Q2m gene competes with the endogenous human gene for
specific transcriptional factors . However, other transfected Daudi lines will need
to be examined to determine whether this is a general phenomenon .
Discussion
The biosynthesis and assembly of class I MHC heavy chains and ,Q2m have
been studied both in mouse (35), and in greater detail, in human systems (9, 36-
39) . In similar fashion to other cell surface and secretory proteins, both the
heavy chain and ,l2m are synthesized on membrane-bound polysomes, and in
both cases the primary translation products contain NH2-terminal signal se-
quences that direct thesegregation oftheseproteins in theendoplasmicreticulum
(9, 35) . The signal peptides are cleaved off sometime after synthesis of the
polypeptide chains . While the heavy chain becomes anchored in the membrane
by meansof its hydrophobictransmembrane sequence near the COOH-terminus,
02m lacks such a sequence and is expressed on the cell surface only by virtue of294
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its association with class I heavy chains. N-linked glycosylation of the heavy chain
begins cotranslationally, but studies with tunicamycin indicate that it is not
required for membrane insertion, association with ,Q2m, or surface expression
(9, 35, 37). Studies in human lymphoblastoid cell lineshave shown that completed
heavy chains bearing the high mannose (endoglycosidase H-sensitive) form of
N-linked oligosaccharide are initially found unassociated with 02m immediately
after synthesis (36). Association with 02m, which is not glycosylated, occurs soon
thereafter (within 5-15 min), and this results in a change in conformation that
alters the antigenic properties of the heavy chain (36, 39). The heavy chain can
associate with a pool of presynthesized 02m (37). After association, the high-
mannose form ofoligosaccharide on the heavy chain is converted to the complex
form (endoglycosidase H-resistant), a modification that takes place in the Golgi
complex (36, 37, 39), and finally mature heterodimeric class I molecules are
found on the cell surface from 30 to 60 min after initial synthesis, depending on
the cell line (36, 37). Analysis of the biosynthesis and assembly of mouse and
human heavy chain and ,Q2m in cell-free translation systems supports the conclu-
sions of the in vivo studies (9, 35, 38). Studies of the intracellular transport of
human class I proteins after mRNA translation in Xenopus laevis oocytes have
further shown that in this in vivo, albeit nonmammalian system, ,02m is secreted
into the medium when translated in the absence of heavy chain, while heavy
chains are retained in the endoplasmic reticulum if translated in the absence of
/02m (39). In contrast, when 02m is present, the heavy chains are transported at
least as far as the cis-Golgi where the N-linked oligosaccharides are converted to
an endoglycosidase H-resistant form (38). These findings suggest that ,02m is
required for the intracellular transport of class I heavy chains in the oocyte
system .
Studies of the Daudi cell line have added greatly to the understanding of class
I protein biosynthesis. Daudi is a Burkitt lymphoma-derived lymphoblastoid cell
line (17) which lacks cell surface expression of class I HLA molecules (40). Daudi
cells have been shown to contain mRNA for both class I heavy chains and for
02m (9, 41, 42), but the latter is not translatable because of a mutation in the
initiation codon (43) . As a result, no human 02m protein can be synthesized. In
contrast, the heavy chain mRNA can be translated in vitro and in vivo, and
cytoplasmic heavy chain can be immunoprecipitated by antiserum specific for
dissociated HLA-A and -B heavy chains but not by alloantibodies or the mAb
W6/32 (9). None of this heavy chain can be detected on the cell surface (9). The
intracellular Daudi heavy chains appear to be processed normally and glycosy-
lated (9), but the N-linked oligosaccharides remain in the endoglycosidase H-
sensitive form (37). These results suggest that /02m is required for the heavy
chain to be transported to the Golgi region, where the carbohydrate is converted
to the complex form (37). Addition of purified 02m to whole cell lysates of
Daudi does not result in association of the two chains (36), perhaps because of
an alteration in conformation or glycosylation as compared to heavy chains in
the presence of (02m (36). In contrast, the heavy chains synthesized by Daudi are
capable of associating with human or mouse 02m in somatic cell hybrids, and
such hybrids express Daudi-specific HLA-A and -B molecules on the cell surface
(7, 8). These studies have led to the conclusion that ,02m is required for heavy
chains to be transported to thecell surface. A similar conclusion has been reachedSEONG ET AL.
￿
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in studies of mutants of the mouse R1 thymoma cell line (10-13). Four such
mutants have been examined and each lacks expression of cell surface class I
molecules (H-2K, -D, and TL) as determined by quantitative cytotoxic immu-
noabsorption. For one of these mutants an antiserum specific for isolated H-2
heavy chains has been used, and this reagent did not immunoprecipitate any
heavy chain from the cell surface (16). Each of the four mutants has been shown
to have defects in both chromosomal copies of the 02m gene, thereby preventing
synthesis of 02m protein (12, 13). As in the case of Daudi, cell surface expression
of class I molecules can be rescued by somatic cell fusion to a mouse cell line
expressing 02m (11, 13).
Although the studies with Daudi and the R1 mutants support the hypothesis
that ,Q2m is required for cell surface expression of class I molecules, they do not
constitute proof, because more than one defect may be complemented in the
generation of somatic cell hybrids. These arguments have taken on greater
significance because of recent studies indicating that the H-2Db molecule can be
expressed on the surface of mouse cells in the absence of 02m. Such expression
was first suggested by Potter et al . (14, 15) as a result of their analysis ofa mutant
cell line (EL4/MAR) derived from the EL4 thymoma line. However, EL4/MAR
clearly expresses intracellular 02m, and the conclusion that Db is expressed on
the surface ofthis cell without #2m has been challenged (16, 44). While providing
an alternative explanation for the results of Potter et al . (14, 15) with EL4/MAR,
Allen et al. (16) have provided strong evidence that Db can indeed be expressed
on the cell surface as an isolated heavy chain after transfection of the Db gene
into one of the #2m-deficient R1 mutant cell lines. However this molecule could
not be recognized by mAbs specific for domains 1 or 2 of the Db molecule, or
by Db-restricted CTLs. In contrast, a mAb specific for domain 3 (membrane-
proximal domain) of Db and the rabbit antiserum specific for isolated heavy
chains could immunoprecipitate large amounts of the isolated Db chain from the
cell surface. It was concluded that the conformation of isolated cell surface Db is
very different from that present in heterodimers with #2m. These results
correlate well with studies of changes in antigenicity of human heavy chains
during biosynthesis and assembly (9, 36, 39). The fact that the putative isolated
Db heavy chain expressed by EL4/MAR was recognized both by allospecific
CTLs and by a Db domain 1-specific mAb that did not react with the Db-
transfected R1 mutant cell (14) led Allen et al. to question the interpretation of
the EL4/MAR results (16). They suggested that endogenous 02m is probably
used to transport Db to the surface in EL4/MAR, and then is exchanged
essentially completely with fetal bovine 02m in the growth medium. In anyevent,
the results of Allen et al . (16) indicate that at least for Db, a class I heavy chain
that is not associated with #2m can be transported to the cell surface. We
therefore felt it important to reexamine the defect in Daudi cells by establishing
whether the lack of cell surface class I molecules was solely a result of the absence
of 02m. Our results show that introduction of the isolated mouse ,82m gene is
indeed sufficient to rescue surface expression of Daudi class I molecules. The
antihuman class I mAbs used all recognized the human class I molecule associated
with mouse (02m (and/or fetal bovine ,Q2m from serum). Similarly, two CTL
clones specific for an HLA specificity encoded by Daudi were capable of killing
the transfected Daudi cells, and this killing was indistinguishable whether the296
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cells were grown in FCS or human serum to allow exchange for human 02m.
These results prove conclusively that at least in the case of the class I molecules
of Daudi, 02m is required for cell surface expression. It may well be that Db is a
unique or at least unusual class I molecule with regard to its ability to be
expressed on the cell surface without 02m.
Summary
The Daudi cell line is a B-lymphoblastoid line derived from a Burkitt lym-
phoma. Daudi cells lack cell surface expression of class I HLA molecules despite
the presence of intracellular class I heavy chains. They have a defect in the gene
encoding 02-microglobulin (02m), resulting in lack of translatable mRNA for this
protein. It has been thought that this deficiency is responsible for the lack of cell
surface class I expression. However, data have recently been presented demon-
strating that at least one mouse class I heavy chain can be expressed on the cell
surface in the absence of 02m. These results raised the questions of whether the
lack of 02m is the only defect in Daudi and whether transfer of this single gene
could restore surface class I expression. We found that transfection of the mouse
02m gene into Daudi indeed rescued cell surface expression of class I HLA
molecules, and that these molecules could be recognized both by monomorphic
and allospecific mAbs. CTL clones specific for HLA-1317 or a determinant
shared by HLA-1317 and HLA-A2 killed the Daudi cells transfected with the
,d2m gene, but not untransfected Daudi or Daudi transfected with vector alone.
Mouse (02m on the transfected Daudi cells could exchange with human (32m
when the cells were incubated in human serum. This exchange did not alter the
ability of the cells to be killed by the specific CTLs. These results demonstrate
that the lack of Q2m is the sole reason for lack of surface class I molecules in
Daudi cells, and that ,Q2m is required for cell surface expression of the specific
class I heavy chains of Daudi.
We would like to thank Dr. Peter Parham for supplying mAbs and Diane Bet and Kim
Brown for preparation of the manuscript.
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